Cost‐Effectiveness of Ivabradine for Heart Failure in the United States

BACKGROUND: Ivabradine is a heart rate–lowering agent approved to reduce the risk of hospitalization for worsening heart failure. This study assessed the cost‐effectiveness of adding ivabradine to background therapy in the United States from the perspective of a commercial or Medicare Advantage paye...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Heart Assoc
Main Authors: Kansal, Anuraag R., Cowie, Martin R., Kielhorn, Adrian, Krotneva, Stanimira, Tafazzoli, Ali, Zheng, Ying, Yurgin, Nicole
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889192/
https://ncbi.nlm.nih.gov/pubmed/27153871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003221
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker